Cloud Alpha Capital Management Limited Editas Medicine, Inc. Call Options Transaction History

Cloud Alpha Capital Management Limited

  • $1.16 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$39.27 - $72.94 $25.3 Million - $47 Million
-645,000 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$31.29 - $56.64 $10.5 Million - $19 Million
335,000 Added 108.06%
645,000 $36.5 Million
Q4 2020

Mar 19, 2021
BUY
$27.07 - $84.35 $8.39 Million - $26.1 Million
310,000 New
310,000 $21.7 Million

Others Institutions Holding EDIT

# of Institutions
251
Shares Held
58.7M
Call Options Held
494K
Put Options Held
417K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $232M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Cloud Alpha Capital Management Limited Portfolio

Follow Cloud Alpha Capital Management Limited and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Alpha Capital Management Limited, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Alpha Capital Management Limited with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email